Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by robergeaon Oct 25, 2016 1:03pm
232 Views
Post# 25383277

RE:TST

RE:TSTI am curious as to why K2 was buying TST at .135. The .005 arbittrage is not much but still 3.7% over 3 months which would not be bad but that is based on cash value, not based on avg pps of 5 days.... so that 3.7% is not really the actual return. Or they were buying on behalf of PLI to make sure the vote would be a yes. Or they wanted in PLI but could not get in without inflating the pps if they were buying in the market so bought TST and now shorting PLI to bring the ratio in their favour. Lots of ??? as far as what their strategy was. There are probably other reasons but I am a bit puzzled. FYI, I am long PLI and happy with the deal.
Bullboard Posts